Trial · NCT04526574
Results by group252
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 252
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination With 20vPnC | (SIIV+20vPnC)/Saline: Coadministration | Redness: Any | 6.3 | 95% Confidence Interval 4.8 to 8.1 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination With 20vPnC | (SIIV+Saline)/20vPnC: Separate Administration | Redness: Any | 7.4 | 95% Confidence Interval 5.7 to 9.3 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination With 20vPnC | (SIIV+20vPnC)/Saline: Coadministration | Redness: Mild | 4.0 | 95% Confidence Interval 2.8 to 5.5 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination With 20vPnC | (SIIV+Saline)/20vPnC: Separate Administration | Redness: Mild | 3.3 | 95% Confidence Interval 2.2 to 4.7 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination With 20vPnC | (SIIV+20vPnC)/Saline: Coadministration | Redness: Moderate | 2.1 | 95% Confidence Interval 1.2 to 3.2 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination With 20vPnC | (SIIV+Saline)/20vPnC: Separate Administration | Redness: Moderate | 3.3 | 95% Confidence Interval 2.2 to 4.7 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination With 20vPnC | (SIIV+20vPnC)/Saline: Coadministration | Redness: Severe | 0.2 | 95% Confidence Interval 0.0 to 0.8 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination With 20vPnC | (SIIV+Saline)/20vPnC: Separate Administration | Redness: Severe | 0.8 | 95% Confidence Interval 0.3 to 1.7 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination With 20vPnC | (SIIV+20vPnC)/Saline: Coadministration | Swelling: Any | 8.2 | 95% Confidence Interval 6.5 to 10.2 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination With 20vPnC | (SIIV+Saline)/20vPnC: Separate Administration | Swelling: Any | 7.8 | 95% Confidence Interval 6.1 to 9.8 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination With 20vPnC | (SIIV+20vPnC)/Saline: Coadministration | Swelling: Mild | 5.0 | 95% Confidence Interval 3.7 to 6.7 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination With 20vPnC | (SIIV+Saline)/20vPnC: Separate Administration | Swelling: Mild | 4.4 | 95% Confidence Interval 3.2 to 6.0 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination With 20vPnC | (SIIV+20vPnC)/Saline: Coadministration | Swelling: Moderate | 2.9 | 95% Confidence Interval 1.9 to 4.2 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination With 20vPnC | (SIIV+Saline)/20vPnC: Separate Administration | Swelling: Moderate | 3.3 | 95% Confidence Interval 2.2 to 4.7 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination With 20vPnC | (SIIV+20vPnC)/Saline: Coadministration | Swelling: Severe | 0.3 | 95% Confidence Interval 0.1 to 1.0 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination With 20vPnC | (SIIV+Saline)/20vPnC: Separate Administration | Swelling: Severe | 0.1 | 95% Confidence Interval 0.0 to 0.6 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination With 20vPnC | (SIIV+20vPnC)/Saline: Coadministration | Pain at the injection site: Any | 48.9 | 95% Confidence Interval 45.5 to 52.2 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination With 20vPnC | (SIIV+Saline)/20vPnC: Separate Administration | Pain at the injection site: Any | 51.5 | 95% Confidence Interval 48.1 to 54.9 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination With 20vPnC | (SIIV+20vPnC)/Saline: Coadministration | Pain at the injection site: Mild | 41.0 | 95% Confidence Interval 37.7 to 44.3 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination With 20vPnC | (SIIV+Saline)/20vPnC: Separate Administration | Pain at the injection site: Mild | 42.9 | 95% Confidence Interval 39.6 to 46.3 | Percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04526574/results